Advertisement

Articles

New Additions to the “Never Events” List

You are probably familiar with the CMS “never events” initiative. CMS has decided it will not reimburse hospitals for treatment related to complications that it says should never occur. Here is the current list. Foreign object...

Read More

FDA Approves Lucentis for Diabetic Macular Edema

Genentech, a member of the Roche Group, today announced that Lucentis® (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in...

Read More

For latest news and updates
Email-id is invalid